| 1 |
Huang J, Yuan W, Chen B, Li G, Chen X. LncRNA ELFN1-AS1 upregulates TRIM29 by suppressing miR-211-3p to promote gastric cancer progression. Acta Biochim Biophys Sin (Shanghai) 2023. [PMID: 36876422 DOI: 10.3724/abbs.2023023] [Reference Citation Analysis]
|
| 2 |
Zhao B, Fang F, Liao Y, Chen Y, Wang F, Ma Y, Wei C, Zhao J, Ji H, Wang D, Tang D. Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer. BMC Bioinformatics 2023;24:100. [PMID: 36935487 DOI: 10.1186/s12859-023-05228-w] [Reference Citation Analysis]
|
| 3 |
Zhou X, Mitra R, Hou F, Zhou S, Wang L, Jiang W. Genomic Landscape and Potential Regulation of RNA Editing in Drug Resistance. Adv Sci (Weinh) 2023;:e2207357. [PMID: 36912579 DOI: 10.1002/advs.202207357] [Reference Citation Analysis]
|
| 4 |
Jiang M, Fang C, Ma Y. Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Gastric Cancer. Biomolecules 2023;13:469. [DOI: 10.3390/biom13030469] [Reference Citation Analysis]
|
| 5 |
Yan W, Chen Y, Hu G, Shi T, Liu X, Li J, Sun L, Qian F, Chen W. MiR-200/183 family-mediated module biomarker for gastric cancer progression: an AI-assisted bioinformatics method with experimental functional survey. J Transl Med 2023;21:163. [PMID: 36864416 DOI: 10.1186/s12967-023-04010-z] [Reference Citation Analysis]
|
| 6 |
Jin Y, Cao J, Cheng H, Hu X. LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma. J Chemother 2023;:1-15. [PMID: 36797828 DOI: 10.1080/1120009X.2023.2177807] [Reference Citation Analysis]
|
| 7 |
Shirani-Bidabadi S, Tabatabaee A, Tavazohi N, Hariri A, Aref AR, Zarrabi A, Casarcia N, Bishayee A, Mirian M. CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer. Eur J Cell Biol 2023;102:151299. [PMID: 36809688 DOI: 10.1016/j.ejcb.2023.151299] [Reference Citation Analysis]
|
| 8 |
Hu Y, Li G, Ma Y, Luo G, Wang Q, Zhang S. Effect of Exosomal lncRNA MALAT1/miR-370-3p/STAT3 Positive Feedback Loop on PI3K/Akt Pathway Mediating Cisplatin Resistance in Cervical Cancer Cells. J Oncol 2023;2023:6341011. [PMID: 36793374 DOI: 10.1155/2023/6341011] [Reference Citation Analysis]
|
| 9 |
Javed A, Yarmohammadi M, Korkmaz KS, Rubio-Tomás T. The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer. Int J Mol Sci 2023;24. [PMID: 36769170 DOI: 10.3390/ijms24032848] [Reference Citation Analysis]
|
| 10 |
Sun Y, Sun F, Jin J, Xu W, Qian H. Exosomal LncRNAs in Gastrointestinal Cancer: Biological Functions and Emerging Clinical Applications. Cancers (Basel) 2023;15. [PMID: 36765913 DOI: 10.3390/cancers15030959] [Reference Citation Analysis]
|
| 11 |
She K, He S, Lu X, Yu S, Li M, Xiong W, Zhou M. LncRNA SNHG7 promotes non-small cell lung cancer progression and cisplatin resistance by inducing autophagic activity. J Thorac Dis 2023;15:155-67. [PMID: 36794139 DOI: 10.21037/jtd-22-1826] [Reference Citation Analysis]
|
| 12 |
Kuang Z, Yang H, Cheng S, Zhou X, Chen L, Zhang Y, Zhang J. Silencing of circ_002136 sensitizes gastric cancer to paclitaxel by targeting the miR-16-5p/HMGA1 axis. Open Med (Wars) 2023;18:20220625. [PMID: 36760722 DOI: 10.1515/med-2022-0625] [Reference Citation Analysis]
|
| 13 |
Zhao B, Liao Y, Chen Y, Wang F, Ma Y, Wei C, Zhao J, Ji H, Wang D, Tang D. Novel M7G-Related lncRNA Signature for Predicting Overall Survival in Patients with Gastric Cancer.. [DOI: 10.21203/rs.3.rs-2464222/v1] [Reference Citation Analysis]
|
| 14 |
Zhang Y, Wang X, Wang S, Liu J, Li R, Li X, Zhang R. Circ-ERBB2 knockdown sensitized colorectal cancer cells to 5-FU via miR-181a-5p/PTEN/Akt pathway. J Biochem Mol Toxicol 2023;:e23297. [PMID: 36639866 DOI: 10.1002/jbt.23297] [Reference Citation Analysis]
|
| 15 |
Yin C, gao M, sun Y, li H, zheng X. A Novel Differentially Expressed Cuproptosis-Related lncRNAs Signature to predict the prognosis and immune characteristics of hepatocellular carcinoma.. [DOI: 10.21203/rs.3.rs-2444600/v1] [Reference Citation Analysis]
|
| 16 |
Lin Y, Tan H, Yu G, Zhan M, Xu B. Molecular Mechanisms of Noncoding RNA in the Occurrence of Castration-Resistant Prostate Cancer. Int J Mol Sci 2023;24. [PMID: 36674820 DOI: 10.3390/ijms24021305] [Reference Citation Analysis]
|
| 17 |
Sun CC, Li L, Jiang ZC, Liu ZC, Wang L, Wang HJ. The Functional Role of LncRNA UCA1 in Pancreatic Cancer: a mini-review. J Cancer 2023;14:275-80. [PMID: 36741256 DOI: 10.7150/jca.79171] [Reference Citation Analysis]
|
| 18 |
Liu R, Han X, Gao S, Chen Y, Zhang J. Hsa_circ_0001944 enhanced GSPT1 expression via sponging miR-498 to promote proliferation and invasion of gastric cancer. J Clin Lab Anal 2023;37:e24810. [PMID: 36597856 DOI: 10.1002/jcla.24810] [Reference Citation Analysis]
|
| 19 |
Yin C, Gao M, Wang Q, Li H. Development and Evaluation of a Novel Cuproptosis-Related lncRNA Signature for Gastric Cancer Prognosis. Comput Math Methods Med 2023;2023:6354212. [PMID: 36820319 DOI: 10.1155/2023/6354212] [Reference Citation Analysis]
|
| 20 |
Zhang Q, Wang C, Yang Y, Xu R, Li Z. LncRNA and its role in gastric cancer immunotherapy. Front Cell Dev Biol 2023;11:1052942. [PMID: 36875764 DOI: 10.3389/fcell.2023.1052942] [Reference Citation Analysis]
|
| 21 |
Usman M, Beilerli A, Sufianov A, Kudryashov V, Ilyasova T, Balaev P, Danilov A, Lu H, Gareev I. Investigations into the impact of non-coding RNA on the sensitivity of gastric cancer to radiotherapy. Front Physiol 2023;14:1149821. [PMID: 36909247 DOI: 10.3389/fphys.2023.1149821] [Reference Citation Analysis]
|
| 22 |
Wu J, Zhou Z, Li J, Liu H, Zhang H, Zhang J, Huang W, He Y, Zhu S, Huo M, Liu M, Zhang C. CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axis. Drug Resist Updat 2023;66:100913. [PMID: 36603431 DOI: 10.1016/j.drup.2022.100913] [Reference Citation Analysis]
|
| 23 |
Zhao Y, Kranjc Brezar S, Grigorieva EV, Skvortsova II. Editorial: Cancer cell reprogramming: Impact on carcinogenesis and cancer progression. Front Oncol 2023;13:1152402. [PMID: 36874087 DOI: 10.3389/fonc.2023.1152402] [Reference Citation Analysis]
|
| 24 |
Lu YH, He DS, Li Y, Wang H, Ma RD. LncRNA BBOX1-AS1 Contributes to the Progression of Esophageal Carcinoma by Targeting the miR-361-3p/COL5A1 Axis. Biochem Genet 2022. [PMID: 36586008 DOI: 10.1007/s10528-022-10307-3] [Reference Citation Analysis]
|
| 25 |
Xu J, Xu Y, Ye G, Qiu J. LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis. J Chemother 2022;:1-12. [PMID: 36548909 DOI: 10.1080/1120009X.2022.2157618] [Reference Citation Analysis]
|
| 26 |
Yang YH, Gu XP, Hu H, Hu B, Wan XL, Gu ZP, Zhong SJ. Ginsenoside Rg1 inhibits nucleus pulposus cell apoptosis, inflammation and extracellular matrix degradation via the YAP1/TAZ pathway in rats with intervertebral disc degeneration. J Orthop Surg Res 2022;17:555. [PMID: 36539815 DOI: 10.1186/s13018-022-03443-4] [Reference Citation Analysis]
|
| 27 |
Malek Abbaslou E, Farsad-akhtar N, Rajabi A, Rasoolnezhad M, Safaralizadeh R. Overexpression of linc RNA-POU3F3 in gastric cancer tissues compared to adjacent non-tumor tissues and its association with clinicopathological characteristics. Gene Reports 2022;29:101696. [DOI: 10.1016/j.genrep.2022.101696] [Reference Citation Analysis]
|
| 28 |
Wang X, Zhang J, Cao G, Hua J, Shan G, Lin W. Emerging roles of circular RNAs in gastric cancer metastasis and drug resistance. J Exp Clin Cancer Res 2022;41:218. [DOI: 10.1186/s13046-022-02432-z] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 29 |
Roh J, Im M, Chae Y, Kang J, Kim W. The Involvement of Long Non-Coding RNAs in Glutamine-Metabolic Reprogramming and Therapeutic Resistance in Cancer. Int J Mol Sci 2022;23. [PMID: 36499136 DOI: 10.3390/ijms232314808] [Reference Citation Analysis]
|
| 30 |
Zeng C, He R, Dai Y, Lu X, Deng L, Zhu Q, Liu Y, Liu Q, Lu W, Wang Y, Jin J. Identification of TGF-β signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1069204] [Reference Citation Analysis]
|
| 31 |
Shu C, Wang C, Chen S, Huang X, Cui J, Li W, Xu B. ERR-activated GPR35 promotes immune infiltration level of macrophages in gastric cancer tissues. Cell Death Discov 2022;8:444. [DOI: 10.1038/s41420-022-01238-4] [Reference Citation Analysis]
|
| 32 |
Su X, Zhou R, Wu Y, Zhang Y, Yu Y, Lu M. Hsa_circ_0005529 promotes ZEB1 expression by regulating miR‐873‐5p and enhancing proliferation, invasion, and migration in gastric cancer cell lines. Clinical Laboratory Analysis 2022. [DOI: 10.1002/jcla.24742] [Reference Citation Analysis]
|
| 33 |
Farzad Rahmani, Pegah Safavi, Ayda Fathollahpour, Fatemeh Tanhaye Kalate Sabz, Parastoo Tajzadeh, Mohsen Arefnezhad, Gordon A. Ferns, Seyed Mahdi Hassanian, Amir Avan. The interplay between non-coding RNAs and Wnt/ß-catenin signaling pathway in urinary tract cancers: from tumorigenesis to metastasis. EXCLI J 2022;21. [PMID: 36483915 DOI: 10.17179/excli2022-5348] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 34 |
Ding D, Zhao Y, Su Y, Yang H, Wang X, Chen L. Prognostic value of antitumor drug targets prediction using integrated bioinformatic analysis for immunogenic cell death-related lncRNA model based on stomach adenocarcinoma characteristics and tumor immune microenvironment. Front Pharmacol 2022;13:1022294. [DOI: 10.3389/fphar.2022.1022294] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 35 |
Feng Y, Li B, Wang K, Li X, Zhang L, Dong X. Epithelial-mesenchymal transition-related long noncoding RNAs in gastric carcinoma. Front Mol Biosci 2022;9:977280. [DOI: 10.3389/fmolb.2022.977280] [Reference Citation Analysis]
|
| 36 |
Wang Y, Li M, Zeng J, Yang Y, Li Z, Hu S, Yang F, Wang N, Wang W, Tie J. MiR-585-5p impedes gastric cancer proliferation and metastasis by orchestrating the interactions among CREB1, MAPK1 and MITF. Front Immunol 2022;13:1008195. [DOI: 10.3389/fimmu.2022.1008195] [Reference Citation Analysis]
|
| 37 |
Wei C, Xie J, Yuan X, Luo Y, Xiao Y, Liao W, Jiang Z. Phosphoglycerate mutase 1 that is essential for glycolysis may act as a novel metabolic target for predicating poor prognosis for patients with gastric cancer. J Clin Lab Anal 2022;:e24718. [PMID: 36181311 DOI: 10.1002/jcla.24718] [Reference Citation Analysis]
|
| 38 |
Yu J, Zhong T, Wang J, Xie S, Liu L, Wang M, Wu F, Xiao C, Chen X, Yan W, Cao Y, Gongye X, Wu M, Chen D. ASPM induces radiotherapy resistance by disrupting microtubule stability leading to chromosome malsegregation in non-small cell lung cancer.. [DOI: 10.21203/rs.3.rs-2091604/v1] [Reference Citation Analysis]
|
| 39 |
Abedi-gaballu F, Kamal Kazemi E, Salehzadeh SA, Mansoori B, Eslami F, Emami A, Dehghan G, Baradaran B, Mansoori B, Cho WC. Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs. Cells 2022;11:2973. [DOI: 10.3390/cells11192973] [Reference Citation Analysis]
|
| 40 |
Zhou X, Lin J, Wang F, Chen X, Zhang Y, Hu Z, Jin X. Circular RNA-regulated autophagy is involved in cancer progression. Front Cell Dev Biol 2022;10:961983. [DOI: 10.3389/fcell.2022.961983] [Reference Citation Analysis]
|
| 41 |
Lin Z, Wu Y, Xu Y, Li G, Li Z, Liu T. Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential. Mol Cancer 2022;21. [DOI: 10.1186/s12943-022-01650-5] [Reference Citation Analysis]
|
| 42 |
Wang Y, Chen X, Jiang F, Shen Y, Fang F, Li Q, Yang C, Dong Y, Shen X. A prognostic signature of pyroptosis-related lncRNAs verified in gastric cancer samples to predict the immunotherapy and chemotherapy drug sensitivity. Front Genet 2022;13:939439. [DOI: 10.3389/fgene.2022.939439] [Reference Citation Analysis]
|
| 43 |
Fan Y, Li X, Sun H, Gao Z, Zhu Z, Yuan K. Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential. Biomolecules 2022;12:1224. [PMID: 36139062 DOI: 10.3390/biom12091224] [Reference Citation Analysis]
|
| 44 |
Yuan W, Huang J, Hou S, Li H, Bie L, Chen B, Li G, Zhou Y, Chen X. The Antigastric Cancer Effect of Triptolide is Associated With H19/NF-κB/FLIP Axis. Front Pharmacol 2022;13:918588. [DOI: 10.3389/fphar.2022.918588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 45 |
Li D, Wang T, Lai J, Zeng D, Chen W, Zhang X, Zhu X, Zhang G, Hu Z. Silencing TRPM2 enhanced erastin- and RSL3-induced ferroptosis in gastric cancer cells through destabilizing HIF-1α and Nrf2 proteins. Cytotechnology. [DOI: 10.1007/s10616-022-00545-z] [Reference Citation Analysis]
|
| 46 |
Hu C, Xu Y, Li F, Mi W, Yu H, Wang X, Wen X, Chen S, Li X, Xu Y, Zhang Y. Identifying and characterizing drug sensitivity-related lncRNA-TF-gene regulatory triplets. Brief Bioinform 2022:bbac366. [PMID: 36007239 DOI: 10.1093/bib/bbac366] [Reference Citation Analysis]
|
| 47 |
Gronnier C. Feature Review Papers on Gastroesophageal Junction and Gastric Cancers. Cancers 2022;14:3979. [DOI: 10.3390/cancers14163979] [Reference Citation Analysis]
|
| 48 |
Lu L, Chen B, Xu Y, Zhang X, Jin L, Qian H, Wang Y, Liang ZF. Role of ferroptosis and ferroptosis-related non-coding RNAs in the occurrence and development of gastric cancer. Front Pharmacol 2022;13:902302. [DOI: 10.3389/fphar.2022.902302] [Reference Citation Analysis]
|
| 49 |
Yin Z, Qiao Y, Shi J, Bu L, Ao L, Tang W, Lu X. Identification of Costimulatory Molecule–Related lncRNAs Associated With Gastric Carcinoma Progression: Evidence From Bioinformatics Analysis and Cell Experiments. Front Genet 2022;13:950222. [DOI: 10.3389/fgene.2022.950222] [Reference Citation Analysis]
|
| 50 |
Meng W, Li Y, Chai B, Liu X, Ma Z. miR-199a: A Tumor Suppressor with Noncoding RNA Network and Therapeutic Candidate in Lung Cancer. IJMS 2022;23:8518. [DOI: 10.3390/ijms23158518] [Reference Citation Analysis]
|
| 51 |
Wang D, Gu Y, Huo C, Zhao Y, Teng M, Li Y. MCEMP1 is a potential therapeutic biomarker associated with immune infiltration in advanced gastric cancer microenvironment. Gene 2022;:146760. [PMID: 35905854 DOI: 10.1016/j.gene.2022.146760] [Reference Citation Analysis]
|
| 52 |
Xu Z, Zhang Y, Dai H, Han B. Epithelial-Mesenchymal Transition-Mediated Tumor Therapeutic Resistance. Molecules 2022;27:4750. [PMID: 35897925 DOI: 10.3390/molecules27154750] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 53 |
Gong YQ, Lu TL, Hou FT, Chen CW. Antisense long non-coding RNAs in gastric cancer. Clin Chim Acta 2022;534:128-37. [PMID: 35872031 DOI: 10.1016/j.cca.2022.07.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 54 |
Liu X, Wang X, Chai B, Wu Z, Gu Z, Zou H, Zhang H, Li Y, Sun Q, Fang W, Ma Z. miR-199a-3p/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer. Int J Biol Sci 2022;18:4187-202. [PMID: 35844793 DOI: 10.7150/ijbs.70312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 55 |
Wu J, Xiao Z, Li H, Zhu N, Gu J, Wang W, Liu C, Wang W, Qin L. Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer. Cancers 2022;14:3487. [DOI: 10.3390/cancers14143487] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 56 |
Wang S, Hong Y, Wang L. Clinical Study on the Evaluation of the Condition of Patients with Gastric Tumors and the Choice of Surgical Treatment by Gastric Ultrasonic Filling Method. Contrast Media Mol Imaging 2022;2022:3960929. [PMID: 35800228 DOI: 10.1155/2022/3960929] [Reference Citation Analysis]
|
| 57 |
Wang G, Yang L, Wang Y, Hu R, Zhang K, Guo T, Chen B, Jiang X, Cui R. Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer. Front Immunol 2022;13:939836. [DOI: 10.3389/fimmu.2022.939836] [Reference Citation Analysis]
|
| 58 |
Liu J, Dai Z, Li M, Wang B, Zhang X, Li F, Zhang M, Zhang W. Circular RNA circMET contributes to tamoxifen resistance of breast cancer cells by targeting miR-204/AHR signaling. Biochemical and Biophysical Research Communications 2022. [DOI: 10.1016/j.bbrc.2022.07.097] [Reference Citation Analysis]
|
| 59 |
Zeng X, Xiao J, Bai X, Liu Y, Zhang M, Liu J, Lin Z, Zhang Z. Research progress on the circRNA/lncRNA–miRNA–mRNA axis in gastric cancer. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.154030] [Reference Citation Analysis]
|
| 60 |
Gu R, Xia Y, Li P, Zou D, Lu K, Ren L, Zhang H, Sun Z. Ferroptosis and its Role in Gastric Cancer. Front Cell Dev Biol 2022;10:860344. [DOI: 10.3389/fcell.2022.860344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 61 |
Li H, Jin X, Zhang S, Li B, Zeng L, He Y, Zhang C, Granito A. APY0201 Represses Tumor Growth through Inhibiting Autophagy in Gastric Cancer Cells. Journal of Oncology 2022;2022:1-16. [DOI: 10.1155/2022/7104592] [Reference Citation Analysis]
|
| 62 |
Zhou M, Dong J, Huang J, Ye W, Zheng Z, Huang K, Pan Y, Cen J, Liang Y, Shu G, Ye S, Lu X, Zhang J. Chitosan-Gelatin-EGCG Nanoparticle-Meditated LncRNA TMEM44-AS1 Silencing to Activate the P53 Signaling Pathway for the Synergistic Reversal of 5-FU Resistance in Gastric Cancer. Adv Sci (Weinh) 2022;:e2105077. [PMID: 35717675 DOI: 10.1002/advs.202105077] [Reference Citation Analysis]
|
| 63 |
Ma T, Wu F, Wu H, Fa Q, Chen Y. Long Non-Coding RNA MCM3AP-AS1: A Crucial Role in Human Malignancies. Pathol Oncol Res 2022;28:1610194. [DOI: 10.3389/pore.2022.1610194] [Reference Citation Analysis]
|
| 64 |
Ding Y, Wang T, Feng Y, Ding X, Li X, Huang Z, Jia Z, Wang J, Yang J. Integrated Analyses Reveal Potential Functional N6-Methyladenosine-Related Long Noncoding RNAs in Adrenocortical Adenocarcinoma. Front Cell Dev Biol 2022;10:851748. [PMID: 35669515 DOI: 10.3389/fcell.2022.851748] [Reference Citation Analysis]
|
| 65 |
Wang Q, Zhang C, Cao S, Zhao H, Jiang R, Li Y. Tumor-derived exosomes orchestrate the microRNA-128-3p/ELF4/CDX2 axis to facilitate the growth and metastasis of gastric cancer via delivery of LINC01091. Cell Biol Toxicol 2022. [PMID: 35674868 DOI: 10.1007/s10565-022-09728-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 66 |
Yu S, Li Z, Tu L, Pu Y, Yan D, Wang X, Zheng X, Yu J. Uricase sensitizes hepatocellular carcinoma cells to 5-fluorouracil through uricase-uric acid-UMP synthase axis. J Physiol Biochem 2022. [PMID: 35674867 DOI: 10.1007/s13105-022-00894-5] [Reference Citation Analysis]
|
| 67 |
Dai L, Wang X, Bai T, Liu J, Chen B, Yang W. Cellular Senescence-Related Genes: Predicting Prognosis in Gastric Cancer. Front Genet 2022;13:909546. [DOI: 10.3389/fgene.2022.909546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 68 |
Zhao G. Albumin/fibrinogen ratio, a predictor of chemotherapy resistance and prognostic factor for advanced gastric cancer patients following radical gastrectomy. BMC Surg 2022;22. [DOI: 10.1186/s12893-022-01657-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 69 |
Kong S, Tian S, Wang Z, Shi Y, Zhang J, Zhuo H. Circular RNA circPFKP suppresses the proliferation and metastasis of gastric cancer cell via sponging miR-644 and regulating ADAMTSL5 expression. Bioengineered 2022;13:12326-37. [PMID: 35587154 DOI: 10.1080/21655979.2022.2073001] [Reference Citation Analysis]
|
| 70 |
Wu Y, Du J. Downregulated Reprimo by LINC00467 participates in the growth and metastasis of gastric cancer. Bioengineered 2022;13:11893-906. [PMID: 35549646 DOI: 10.1080/21655979.2022.2063662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 71 |
Chen Y, Wu Y, Tang M. Downregulation of LINC01857 Increases Sensitivity of Gastric Carcinoma Cells to Cisplatin. Computational and Mathematical Methods in Medicine 2022;2022:1-8. [DOI: 10.1155/2022/3325686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 72 |
Gu J, Ni X, Ji J, Wei G, Shi L, Xu C. Efficacy of Apatinib plus S-1 Therapy in the Treatment of Advanced Gastric Cancer Patients and the Effect on the Levels of Tumor Markers and Th1 and Th2-Like Cytokines. Evid Based Complement Alternat Med 2022;2022:8060026. [PMID: 35529932 DOI: 10.1155/2022/8060026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 73 |
Wang Y, Huang Z, Li B, Liu L, Huang C. The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer. Front Endocrinol 2022;13:863541. [DOI: 10.3389/fendo.2022.863541] [Reference Citation Analysis]
|
| 74 |
Ma Z, Liu G, Hao S, Zhao T, Chang W, Wang J, Ren H, Zhao X, Chen G. PITPNA-AS1/miR-98-5p to Mediate the Cisplatin Resistance of Gastric Cancer. Journal of Oncology 2022;2022:1-14. [DOI: 10.1155/2022/7981711] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 75 |
Deng L, Liu Z, Qian Y, Zhang J. Predicting circRNA-drug sensitivity associations via graph attention auto-encoder. BMC Bioinformatics 2022;23:160. [PMID: 35508967 DOI: 10.1186/s12859-022-04694-y] [Reference Citation Analysis]
|
| 76 |
Chen G, Liao J, Xu Y, Chen Y, Li J, Bu G, Li Q. LINC01232 Promotes Metastasis and EMT by Regulating miR-506-5p/PAK1 Axis in Gastric Cancer. CMAR 2022;Volume 14:1729-40. [DOI: 10.2147/cmar.s352081] [Reference Citation Analysis]
|
| 77 |
Chen D, Wei X, Yang K, Liu X, Song Y, Bai F, Jiang Y, Guo Y, Jha RK. Piperlongumine combined with vitamin C as a new adjuvant therapy against gastric cancer regulates the ROS-STAT3 pathway. J Int Med Res 2022;50:3000605221093308. [PMID: 35481419 DOI: 10.1177/03000605221093308] [Reference Citation Analysis]
|
| 78 |
Xu W, Wang J, Xu J, Li S, Zhang R, Shen C, Xie M, Zheng B, Gu M. Long non-coding RNA DEPDC1-AS1 promotes proliferation and migration of human gastric cancer cells HGC-27 via the human antigen R-F11R pathway. J Int Med Res 2022;50:3000605221093135. [PMID: 35466755 DOI: 10.1177/03000605221093135] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 79 |
Bhardwaj P, Bhandari G, Kumar Y, Gupta S. An Investigational Approach for the Prediction of Gastric Cancer Using Artificial Intelligence Techniques: A Systematic Review. Arch Computat Methods Eng. [DOI: 10.1007/s11831-022-09737-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 80 |
Ji Z, Qiu Y, Cai Q, Xu C. LINC00922 acts as a novel oncogene in gastric cancer. World J Surg Onc 2022;20. [DOI: 10.1186/s12957-022-02569-3] [Reference Citation Analysis]
|
| 81 |
Liu H, Chen Y, Zhou L, Jiang X, Zhou X. MicroRNA-642b-3p functions as an oncomiR in gastric cancer by down-regulating the CUB and sushi multiple domains protein 1/smad axis. Bioengineered 2022;13:9613-27. [PMID: 35412956 DOI: 10.1080/21655979.2022.2056813] [Reference Citation Analysis]
|
| 82 |
Chen X, Hu L, Mao X, Chen H, She Y, Chi H, Zeng H, Guo L, Han Y, Xu Y. Upregulated LINC00922 Promotes Epithelial-Mesenchymal Transition and Indicates a Dismal Prognosis in Gastric Cancer. Journal of Oncology 2022;2022:1-17. [DOI: 10.1155/2022/1608936] [Reference Citation Analysis]
|
| 83 |
Yang X, Ma L, Fang S, Song Y, Zhu S, Jin C, Liu W, Lu Q, Zeng L, Cui S. Construction of a Competing Endogenous RNA Network and Identification of Potential Regulatory Axes in Gastric Cancer Chemoresistance. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153904] [Reference Citation Analysis]
|
| 84 |
Wu D, Wang Z. Gastric Cancer Cell-Derived Kynurenines Hyperactive Regulatory T Cells to Promote Chemoresistance via the IL-10/STAT3/BCL2 Signaling Pathway. DNA Cell Biol 2022. [PMID: 35353612 DOI: 10.1089/dna.2021.0936] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 85 |
Zhu J, Zhang Y, Chen X, Bian Y, Li J, Wang K. The Emerging Roles of LINC00665 in Human Cancers. Front Cell Dev Biol 2022;10:839177. [DOI: 10.3389/fcell.2022.839177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 86 |
Huang J, Chen W, Chen C, Jie Z, Xiao T. Comprehensive Analysis and Prognosis Prediction of N6-Methyladenosine-Related lncRNAs in Immune Microenvironment Infiltration of Gastric Cancer. IJGM 2022;Volume 15:2629-43. [DOI: 10.2147/ijgm.s349399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 87 |
Luo Y, Xiang W, Liu Z, Yao L, Tang L, Tan W, Ye P, Deng J, Xiao J. Functional role of the SLC7A11-AS1/xCT axis in the development of gastric cancer cisplatin-resistance by a GSH-dependent mechanism. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.03.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 88 |
Di J, Chai Y, Yang X, Dong H, Jiang B, Ji F. ELP6 and PLIN5 Mutations Were Probably Prognostic Biomarkers for Patients With Gastric Cancer. Front Med (Lausanne) 2022;9:803617. [PMID: 35223903 DOI: 10.3389/fmed.2022.803617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 89 |
Zhang H, Zhang Y, Xia T, Lu L, Luo M, Chen Y, Liu Y, Li Y. The Role of Keratin17 in Human Tumours. Front Cell Dev Biol 2022;10:818416. [DOI: 10.3389/fcell.2022.818416] [Reference Citation Analysis]
|
| 90 |
Ling Z, Zhang J, Liu Q. Oncogenic Forkhead box D3 antisense RNA 1 promotes cell survival and confers temozolomide resistance in glioblastoma cells through the miR-128-3p/WEE1 G2 checkpoint kinase axis. Bioengineered 2022;13:6012-23. [PMID: 35191808 DOI: 10.1080/21655979.2022.2042133] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 91 |
Liu Z, Hu K, Wang X, Zhang Y, Wang W, Wu Y. lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells. Open Medicine 2022;17:266-79. [DOI: 10.1515/med-2021-0406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 92 |
Liu Z, Wang P, Yuan S, Wang Y, Cao P, Wen F, Li H, Zhu L, Liang L, Wang Z, Hu B, Zheng F, Liu J, Xiao X, Zhang J. LncRNA BC200/miR-150-5p/MYB positive feedback loop promotes the malignant proliferation of myelodysplastic syndrome. Cell Death Dis 2022;13:126. [PMID: 35136029 DOI: 10.1038/s41419-022-04578-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 93 |
Ma W, Zhao X, Gao Y, Yao X, Zhang J, Xu Q. Circular RNA circ_UBAP2 facilitates the progression of osteosarcoma by regulating microRNA miR-637/high-mobility group box (HMGB) 2 axis. Bioengineered 2022;13:4411-27. [PMID: 35114890 DOI: 10.1080/21655979.2022.2033447] [Reference Citation Analysis]
|
| 94 |
Yeoh KG, Tan P. Mapping the genomic diaspora of gastric cancer. Nat Rev Cancer 2022;22:71-84. [PMID: 34702982 DOI: 10.1038/s41568-021-00412-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 31.0] [Reference Citation Analysis]
|
| 95 |
Li J, Guo S, Sun Z, Fu Y. Noncoding RNAs in Drug Resistance of Gastrointestinal Stromal Tumor. Front Cell Dev Biol 2022;10:808591. [DOI: 10.3389/fcell.2022.808591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 96 |
Liu Y, Ao X, Wang Y, Li X, Wang J. Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance. Front Oncol 2022;12:841411. [DOI: 10.3389/fonc.2022.841411] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 97 |
Yang Z, Deng W, Zhang X, An Y, Liu Y, Yao H, Zhang Z. Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies. Front Oncol 2021;11:789330. [PMID: 35083147 DOI: 10.3389/fonc.2021.789330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 98 |
He L, Lin M, Shen J, Qi H. Emerging role of exosomal long non-coding RNAs in lung cancer. Mol Biol Rep 2022. [PMID: 35083616 DOI: 10.1007/s11033-022-07169-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 99 |
Liu XY, Zhang Q, Guo J, Zhang P, Liu H, Tian ZB, Zhang CP, Li XY. The Role of Circular RNAs in the Drug Resistance of Cancers. Front Oncol 2021;11:790589. [PMID: 35070998 DOI: 10.3389/fonc.2021.790589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 100 |
Wang M, Yu F, Zhang Y, Zhang L, Chang W, Wang K. The Emerging Roles of Circular RNAs in the Chemoresistance of Gastrointestinal Cancer. Front Cell Dev Biol 2022;10:821609. [DOI: 10.3389/fcell.2022.821609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 101 |
Gu H, Zhong Y, Liu J, Shen Q, Wei R, Zhu H, Zhang X, Xia X, Yao M, Ni M. The Role of miR-4256/HOXC8 Signaling Axis in the Gastric Cancer Progression: Evidence From lncRNA-miRNA-mRNA Network Analysis. Front Oncol 2022;11:793678. [DOI: 10.3389/fonc.2021.793678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 102 |
Shan G, Huang T, Tang T. Long non-coding RNA MEG8 induced by PLAG1 promotes clear cell renal cell carcinoma through the miR-495-3p/G3BP1 axis. Pathol Res Pract 2022;229:153734. [PMID: 35030351 DOI: 10.1016/j.prp.2021.153734] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 103 |
Wang L, Zhong C. gGATLDA: lncRNA-disease association prediction based on graph-level graph attention network. BMC Bioinformatics 2022;23:11. [PMID: 34983363 DOI: 10.1186/s12859-021-04548-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 104 |
Xu R, Yu J, Song S, Sun D, Xiu L, Xu J, Zhao J, Liu X, Ji Q, Yue X. Long non-coding RNA ncRuPAR regulates gastric cancer cell proliferation and apoptosis via phosphoinositide 3-kinase/protein kinase B signaling. Int J Med Sci 2022;19:1835-46. [PMID: 36438913 DOI: 10.7150/ijms.76664] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 105 |
Yi C, Zhang X, Chen X, Huang B, Song J, Ma M, Yuan X, Zhang C. A novel 8-genome instability-associated lncRNAs signature predicting prognosis and drug sensitivity in gastric cancer. Int J Immunopathol Pharmacol 2022;36:3946320221103195. [PMID: 35696730 DOI: 10.1177/03946320221103195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 106 |
Yue Y, Lin X, Qiu X, Yang L, Wang R. The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer. Front Cell Dev Biol 2021;9:802745. [PMID: 34966746 DOI: 10.3389/fcell.2021.802745] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 107 |
Xia M, Zu X, Chen Z, Wen G, Zhong J. Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance. Cancer Lett 2021;523:100-10. [PMID: 34601022 DOI: 10.1016/j.canlet.2021.09.038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 108 |
Sun L, Zhang J, Xu M, Zhang L, Tang Q, Chen J, Gong M, Sun S, Ge H, Wang S, Liang X, Cui L. Ultrasound Microbubbles Mediated Sonosensitizer and Antibody Co-delivery for Highly Efficient Synergistic Therapy on HER2-Positive Gastric Cancer. ACS Appl Mater Interfaces 2021. [PMID: 34961307 DOI: 10.1021/acsami.1c21924] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 109 |
Liu Y, Ao X, Ji G, Zhang Y, Yu W, Wang J. Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer. Front Oncol 2021;11:768918. [PMID: 34912714 DOI: 10.3389/fonc.2021.768918] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 110 |
Zhang R, Zhao H, Yuan H, Wu J, Liu H, Sun S, Zhang Z, Wang J. CircARVCF Contributes to Cisplatin Resistance in Gastric Cancer by Altering miR-1205 and FGFR1. Front Genet 2021;12:767590. [PMID: 34899853 DOI: 10.3389/fgene.2021.767590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 111 |
Xi SJ, Cai WQ, Wang QQ, Peng XC. Role of circular RNAs in gastrointestinal tumors and drug resistance. World J Clin Cases 2021; 9(34): 10400-10417 [PMID: 35004973 DOI: 10.12998/wjcc.v9.i34.10400] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 112 |
Rao X, Liu X, Liu N, Zhang Y, Zhang Z, Zhou L, Han G, Cen R, Shi N, Zhu H, Gong H, Huang C, Ji Q, Li Q. Long noncoding RNA NEAT1 promotes tumorigenesis in H. pylori gastric cancer by sponging miR-30a to regulate COX-2/BCL9 pathway. Helicobacter 2021;26:e12847. [PMID: 34396632 DOI: 10.1111/hel.12847] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 113 |
Shafabakhsh R, Arianfar F, Vosough M, Mirzaei HR, Mahjoubin-Tehran M, Khanbabaei H, Kowsari H, Shojaie L, Azar MEF, Hamblin MR, Mirzaei H. Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance. Cancer Gene Ther 2021;28:1229-55. [PMID: 33432087 DOI: 10.1038/s41417-020-00272-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 114 |
Li X, Li Z, Liu P, Ai S, Sun F, Hu Q, Dong Y, Xia X, Guan W, Liu S. Novel CircRNAs in Hub ceRNA Axis Regulate Gastric Cancer Prognosis and Microenvironment. Front Med (Lausanne) 2021;8:771206. [PMID: 34820403 DOI: 10.3389/fmed.2021.771206] [Reference Citation Analysis]
|
| 115 |
Chen D, Ping S, Xu Y, Wang M, Jiang X, Xiong L, Zhang L, Yu H, Xiong Z. Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications. Front Cell Dev Biol 2021;9:732036. [PMID: 34805143 DOI: 10.3389/fcell.2021.732036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 116 |
Zhao Z, Liu H, Zhou X, Fang D, Ou X, Ye J, Peng J, Xu J. Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer. J Oncol 2021;2021:6718443. [PMID: 34790235 DOI: 10.1155/2021/6718443] [Cited by in Crossref: 65] [Cited by in F6Publishing: 80] [Article Influence: 32.5] [Reference Citation Analysis]
|
| 117 |
Zhang Z, Hu H, Li Q, Yi F, Liu Y. A Novel Circular RNA circPTCD3 Promotes Breast Cancer Progression Through Sponging miR-198. Cancer Manag Res 2021;13:8435-43. [PMID: 34785951 DOI: 10.2147/CMAR.S256091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 118 |
Niclauss N, Gütgemann I, Dohmen J, Kalff JC, Lingohr P. Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives. Cancers (Basel) 2021;13:5660. [PMID: 34830815 DOI: 10.3390/cancers13225660] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 119 |
Chen C, Guo Y, Guo Y, Wu X, Si C, Xu Y, Kang Q, Sun Z. m6A Modification in Non-Coding RNA: The Role in Cancer Drug Resistance. Front Oncol 2021;11:746789. [PMID: 34745970 DOI: 10.3389/fonc.2021.746789] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 120 |
Jiang H, Hu K, Xia Y, Liang L, Zhu X. Long Noncoding RNA KLF3-AS1 Acts as an Endogenous RNA of miR-223 to Attenuate Gastric Cancer Progression and Chemoresistance. Front Oncol 2021;11:704339. [PMID: 34745937 DOI: 10.3389/fonc.2021.704339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 121 |
Hou M, Li C, Dong S. LINC00963/miR-4458 regulates the effect of oxaliplatin in gastric cancer by mediating autophagic flux through targeting of ATG16L1. Sci Rep 2021;11:20951. [PMID: 34697403 DOI: 10.1038/s41598-021-98728-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 122 |
Wang Z, Wang Z, Hu X, Han Q, Chen K, Pang G. Extracellular Matrix-Associated Pathways Promote the Progression of Gastric Cancer by Impacting the Dendritic Cell Axis. Int J Gen Med 2021;14:6725-39. [PMID: 34675633 DOI: 10.2147/IJGM.S334245] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 123 |
Song X, Guo Y, Song P, Duan D, Guo W. Non-coding RNAs in Regulating Tumor Angiogenesis. Front Cell Dev Biol 2021;9:751578. [PMID: 34616746 DOI: 10.3389/fcell.2021.751578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 124 |
Geng X, Wang J, Zhang C, Zhou X, Jing J, Pan W. Circular RNA circCOL6A3_030 is involved in the metastasis of gastric cancer by encoding polypeptide. Bioengineered 2021;12:8202-16. [PMID: 34595992 DOI: 10.1080/21655979.2021.1979915] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 125 |
Ou C, He X, Liu Y, Zhang X. lncRNA cytoskeleton regulator RNA (CYTOR): Diverse functions in metabolism, inflammation and tumorigenesis, and potential applications in precision oncology. Genes & Diseases 2021. [DOI: 10.1016/j.gendis.2021.08.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 126 |
Zhang SX, Liu W, Ai B, Sun LL, Chen ZS, Lin LZ. Current Advances and Outlook in Gastric Cancer Chemoresistance: A Review. Recent Pat Anticancer Drug Discov 2021. [PMID: 34587888 DOI: 10.2174/1574892816666210929165729] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 127 |
Smolarz B, Durczyński A, Romanowicz H, Hogendorf P. The Role of microRNA in Pancreatic Cancer. Biomedicines 2021;9. [PMID: 34680441 DOI: 10.3390/biomedicines9101322] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 128 |
Cheng Z, Liu G, Huang C, Zhao X. KLF5 activates lncRNA DANCR and inhibits cancer cell autophagy accelerating gastric cancer progression. NPJ Genom Med 2021;6:75. [PMID: 34548487 DOI: 10.1038/s41525-021-00207-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 129 |
Su R, Zhao E, Zhang J. miR-496 inhibits proliferation via LYN and AKT pathway in gastric cancer. Open Med (Wars) 2021;16:1206-14. [PMID: 34514167 DOI: 10.1515/med-2021-0313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 130 |
Li H, Wang C, Lan L, Wu W, Evans I, Ruiz EJ, Yan L, Zhou Z, Oliveira JM, Reis RL, Hu Z, Chen W, Behrens A, He Y, Zhang C. PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway. Front Cell Dev Biol 2021;9:719192. [PMID: 34497808 DOI: 10.3389/fcell.2021.719192] [Reference Citation Analysis]
|
| 131 |
Liu L, Dai A, Zhang Z, Ning M, Han D, Li L, Li Z. LncRNA PITPNA-AS1 promotes gastric cancer by increasing SOX4 expression via inhibition of miR-92a-3p. Aging (Albany NY) 2021;13:21191-201. [PMID: 34496348 DOI: 10.18632/aging.203403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 132 |
He T, Yuan C, Zhao C. Long intragenic non-coding RNA p53-induced transcript (LINC-PINT) as a novel prognosis indicator and therapeutic target in cancer. Biomed Pharmacother 2021;143:112127. [PMID: 34474342 DOI: 10.1016/j.biopha.2021.112127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 133 |
Lu Q, Lou J, Cai R, Han W, Pan H. Emerging roles of a pivotal lncRNA SBF2-AS1 in cancers. Cancer Cell Int 2021;21:417. [PMID: 34372871 DOI: 10.1186/s12935-021-02123-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 134 |
de Mello RA, Amaral GA, Neves NM, Lippo EG, Parini F, Xu S, Tolia M, Charalampakis N, Tadokoro H, Castelo-Branco P, Zhu J. Current and potential biomarkers in gastric cancer: a critical review of the literature. Future Oncol 2021;17:3383-96. [PMID: 34291647 DOI: 10.2217/fon-2021-0084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 135 |
Zhou W, Gao M, Liang C, Lin B, Wu Q, Chen R, Xiong X, Chen X, Wang S, Wu L, Wu Y, Li H, Fu X, Hong W. Systematic Understanding of the Mechanism of Baicalin against Gastric Cancer Using Transcriptome Analysis. Biomed Res Int 2021;2021:5521058. [PMID: 34337018 DOI: 10.1155/2021/5521058] [Reference Citation Analysis]
|
| 136 |
Hu X, Lou T, Yuan C, Wang Y, Tu X, Wang Y, Zhang T. Effects of lncRNA ANRIL-knockdown on the proliferation, apoptosis and cell cycle of gastric cancer cells. Oncol Lett 2021;22:621. [PMID: 34267814 DOI: 10.3892/ol.2021.12882] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 137 |
Li Y, Lu L, Wu X, Li Q, Zhao Y, Du F, Chen Y, Shen J, Xiao Z, Wu Z, Hu W, Cho CH, Li M. The Multifaceted Role of Long Non-Coding RNA in Gastric Cancer: Current Status and Future Perspectives. Int J Biol Sci 2021;17:2737-55. [PMID: 34345204 DOI: 10.7150/ijbs.61410] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 138 |
Ni X, Wang Z, Gao D, Yuan H, Sun L, Zhu X, Zhou Q, Yang Z. A description of the relationship in healthy longevity and aging-related disease: from gene to protein. Immun Ageing 2021;18:30. [PMID: 34172062 DOI: 10.1186/s12979-021-00241-0] [Reference Citation Analysis]
|
| 139 |
Ding L, Wang R, Shen D, Cheng S, Wang H, Lu Z, Zheng Q, Wang L, Xia L, Li G. Role of noncoding RNA in drug resistance of prostate cancer. Cell Death Dis 2021;12:590. [PMID: 34103477 DOI: 10.1038/s41419-021-03854-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 140 |
Zheng Q, Jia J, Zhou Z, Chu Q, Lian W, Chen Z. The Emerging Role of Thymopoietin-Antisense RNA 1 as Long Noncoding RNA in the Pathogenesis of Human Cancers. DNA Cell Biol 2021;40:848-57. [PMID: 34096793 DOI: 10.1089/dna.2021.0024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 141 |
Shi H, Huang S, Qin M, Xue X, Guo X, Jiang L, Hong H, Fang J, Gao L. Exosomal circ_0088300 Derived From Cancer-Associated Fibroblasts Acts as a miR-1305 Sponge and Promotes Gastric Carcinoma Cell Tumorigenesis. Front Cell Dev Biol 2021;9:676319. [PMID: 34124064 DOI: 10.3389/fcell.2021.676319] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 142 |
Lin T, Peng W, Mai P, Zhang E, Peng L. Human Gastric Cancer Stem Cell (GCSC) Markers Are Prognostic Factors Correlated With Immune Infiltration of Gastric Cancer. Front Mol Biosci 2021;8:626966. [PMID: 34113647 DOI: 10.3389/fmolb.2021.626966] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 143 |
Razavi ZS, Asgarpour K, Mahjoubin-Tehran M, Rasouli S, Khan H, Shahrzad MK, Hamblin MR, Mirzaei H. Angiogenesis-related non-coding RNAs and gastrointestinal cancer. Mol Ther Oncolytics 2021;21:220-41. [PMID: 34095461 DOI: 10.1016/j.omto.2021.04.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 144 |
Wu SR, Wu Q, Shi YQ. Recent advances of miRNAs in the development and clinical application of gastric cancer. Chin Med J (Engl) 2020;133:1856-67. [PMID: 32649523 DOI: 10.1097/CM9.0000000000000921] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 145 |
Guan B, Ma J, Yang Z, Yu F, Yao J. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling. Environ Toxicol 2021;36:1640-53. [PMID: 33974352 DOI: 10.1002/tox.23160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 146 |
Lu GH, Zhao HM, Liu ZY, Cao Q, Shao RD, Sun G. LncRNA SAMD12-AS1 promotes the progression of gastric cancer via DNMT1/p53 axis. Arch Med Res 2021:S0188-4409(21)00101-6. [PMID: 33962804 DOI: 10.1016/j.arcmed.2021.04.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 147 |
Wang K, Wang T, Gao XQ, Chen XZ, Wang F, Zhou LY. Emerging functions of piwi-interacting RNAs in diseases. J Cell Mol Med 2021;25:4893-901. [PMID: 33942984 DOI: 10.1111/jcmm.16466] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 148 |
Yue C, Yu C, Peng R, Wang J, Li G, Xu L. LINC00665/miR-379-5p/GRP78 regulates cisplatin sensitivity in gastric cancer by modulating endoplasmic reticulum stress. Cytotechnology 2021;73:413-22. [PMID: 34149174 DOI: 10.1007/s10616-021-00466-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 149 |
Gao H, Xu J, Qiao F, Xue L. Depletion of hsa_circ_0000144 Suppresses Oxaliplatin Resistance of Gastric Cancer Cells by Regulating miR-502-5p/ADAM9 Axis. Onco Targets Ther 2021;14:2773-87. [PMID: 33907420 DOI: 10.2147/OTT.S281238] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 150 |
Li M, Zhang S, Ma Y, Yang Y, An R. Role of hsa‑miR‑105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer. Oncol Rep 2021;45:84. [PMID: 33846814 DOI: 10.3892/or.2021.8035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 151 |
Yan X, Zhang M, Li B, Ji X, Wu H, Zhang Q. RAI14 Regulated by circNFATC3/miR-23b-3p axis Facilitates Cell Growth and Invasion in Gastric Cancer. Cell Transplant 2021;30:9636897211007055. [PMID: 33840258 DOI: 10.1177/09636897211007055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 152 |
Chen G, Tang W, Wang S, Long C, He X, Yang D, Peng S. Promising diagnostic and therapeutic circRNAs for skeletal and chondral disorders. Int J Biol Sci 2021;17:1428-39. [PMID: 33867856 DOI: 10.7150/ijbs.57887] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 153 |
Micallef I, Baron B. The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer. Noncoding RNA 2021;7:24. [PMID: 33807355 DOI: 10.3390/ncrna7020024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 154 |
Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther 2021;6:128. [PMID: 33776057 DOI: 10.1038/s41392-021-00507-5] [Cited by in Crossref: 286] [Cited by in F6Publishing: 278] [Article Influence: 143.0] [Reference Citation Analysis]
|
| 155 |
Ni Q, Zhang Y, Tao R, Li X, Zhu J. MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling. Aging (Albany NY) 2021;13:8665-87. [PMID: 33714198 DOI: 10.18632/aging.202679] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 156 |
Mirzaei S, Zarrabi A, Hashemi F, Zabolian A, Saleki H, Azami N, Hamzehlou S, Farahani MV, Hushmandi K, Ashrafizadeh M, Khan H, Kumar AP. Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery. Antioxidants (Basel) 2021;10:349. [PMID: 33652780 DOI: 10.3390/antiox10030349] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 157 |
Chen Q, Tan Y, Zhang C, Zhang Z, Pan S, An W, Xu H. A Weighted Gene Co-Expression Network Analysis-Derived Prognostic Model for Predicting Prognosis and Immune Infiltration in Gastric Cancer. Front Oncol 2021;11:554779. [PMID: 33718128 DOI: 10.3389/fonc.2021.554779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 158 |
Liang LC, Liu LQ, Liu L, Liu DL, He YR, Wan X, Zhu ZQ, Zhang BG, Liu SJ, Wu H, Hu L. Long non-coding RNA BX357664 inhibits gastric cancer progression by sponging miR-183a-3p to regulate the PTEN expression and PI3K/AKT pathway. Food Chem Toxicol 2021;150:112069. [PMID: 33607219 DOI: 10.1016/j.fct.2021.112069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 159 |
Deng P, Sun M, Zhao WY, Hou B, Li K, Zhang T, Gu F. Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis. World J Gastroenterol 2021; 27(6): 487-500 [PMID: 33642823 DOI: 10.3748/wjg.v27.i6.487] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 160 |
Li Z, Lü M, Zhou Y, Xu L, Jiang Y, Liu Y, Li X, Song M. Role of Long Non-Coding RNAs in the Chemoresistance of Gastric Cancer: A Systematic Review. Onco Targets Ther 2021;14:503-18. [PMID: 33500626 DOI: 10.2147/OTT.S294378] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 161 |
Song S, He X, Wang J, Song H, Wang Y, Liu Y, Zhou Z, Yu Z, Miao D, Xue Y. A novel long noncoding RNA, TMEM92-AS1, promotes gastric cancer progression by binding to YBX1 to mediate CCL5. Mol Oncol 2021;15:1256-73. [PMID: 33247987 DOI: 10.1002/1878-0261.12863] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 162 |
Miao X, Liu Y, Fan Y, Wang G, Zhu H. LncRNA BANCR Attenuates the Killing Capacity of Cisplatin on Gastric Cancer Cell Through the ERK1/2 Pathway. Cancer Manag Res 2021;13:287-96. [PMID: 33469371 DOI: 10.2147/CMAR.S269679] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 163 |
Mosca L, Ilari A, Fazi F, Assaraf YG, Colotti G. Taxanes in cancer treatment: Activity, chemoresistance and its overcoming. Drug Resist Updat 2021;54:100742. [PMID: 33429249 DOI: 10.1016/j.drup.2020.100742] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 21.5] [Reference Citation Analysis]
|
| 164 |
Li L, Dong Z, Shi P, Tan L, Xu J, Huang P, Wang Z, Cui H, Yang L. Bruceine D inhibits Cell Proliferation Through Downregulating LINC01667/MicroRNA-138-5p/Cyclin E1 Axis in Gastric Cancer. Front Pharmacol 2020;11:584960. [PMID: 33390953 DOI: 10.3389/fphar.2020.584960] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 165 |
Cui X, Zhang H, Chen T, Yu W, Shen K. Long Noncoding RNA SNHG22 Induces Cell Migration, Invasion, and Angiogenesis of Gastric Cancer Cells via microRNA-361-3p/HMGA1/Wnt/β-Catenin Axis. Cancer Manag Res 2020;12:12867-83. [PMID: 33364835 DOI: 10.2147/CMAR.S281578] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 166 |
Xu B, Mei J, Ji W, Bian Z, Jiao J, Sun J, Shao J. LncRNA SNHG3, a potential oncogene in human cancers. Cancer Cell Int 2020;20:536. [PMID: 33292213 DOI: 10.1186/s12935-020-01608-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 167 |
Lin Z, Lu S, Xie X, Yi X, Huang H. Noncoding RNAs in drug-resistant pancreatic cancer: A review. Biomedicine & Pharmacotherapy 2020;131:110768. [DOI: 10.1016/j.biopha.2020.110768] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 168 |
Li W, Duan J, Shi W, Lei L, Lv P. Long Non-Coding RNA NCK1-AS1 Serves an Oncogenic Role in Gastric Cancer by Regulating miR-137/NUP43 Axis. Onco Targets Ther 2020;13:9929-39. [PMID: 33116577 DOI: 10.2147/OTT.S259336] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 169 |
Xia T, Pan Z, Zhang J. CircPDZD8 promotes gastric cancer progression by regulating CHD9 via sponging miR-197-5p. Aging (Albany NY) 2020;12:19352-64. [PMID: 33049714 DOI: 10.18632/aging.103805] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 170 |
Zhang H, Lu B. The Roles of ceRNAs-Mediated Autophagy in Cancer Chemoresistance and Metastasis. Cancers (Basel) 2020;12:E2926. [PMID: 33050642 DOI: 10.3390/cancers12102926] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 171 |
Li F, Yang Q, He AT, Yang BB. Circular RNAs in cancer: limitations in functional studies and diagnostic potential. Semin Cancer Biol 2020:S1044-579X(20)30207-8. [PMID: 33035655 DOI: 10.1016/j.semcancer.2020.10.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 34] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 172 |
Zhou X, Fan Y, He Y, Mou A, Wang F, Liu Y, Wu Z. Clinicopathological and Prognostic Value of Gastric Carcinoma Highly Expressed Transcript 1 in Cancer: A Meta-Analysis. J Oncol 2020;2020:6341093. [PMID: 32908508 DOI: 10.1155/2020/6341093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 173 |
Song H, Liu D, Dong S, Zeng L, Wu Z, Zhao P, Zhang L, Chen ZS, Zou C. Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications. Signal Transduct Target Ther 2020;5:193. [PMID: 32900991 DOI: 10.1038/s41392-020-00300-w] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 174 |
Liu Y, Ma Y, Li Z, Yang Y, Yu B, Zhang Z, Wang G. Investigation of Inhibition Effect of Gossypol-Acetic Acid on Gastric Cancer Cells Based on a Network Pharmacology Approach and Experimental Validation. Drug Des Devel Ther 2020;14:3615-23. [PMID: 32982170 DOI: 10.2147/DDDT.S256566] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 175 |
Qian C, Xu Z, Chen L, Wang Y, Yao J. Long noncoding RNA LINC01391 restrained gastric cancer aerobic glycolysis and tumorigenesis via targeting miR-12116/CMTM2 axis. J Cancer 2020;11:6264-76. [PMID: 33033510 DOI: 10.7150/jca.48365] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 176 |
Pu Z, Xu M, Yuan X, Xie H, Zhao J. Circular RNA circCUL3 Accelerates the Warburg Effect Progression of Gastric Cancer through Regulating the STAT3/HK2 Axis. Mol Ther Nucleic Acids 2020;22:310-8. [PMID: 33230436 DOI: 10.1016/j.omtn.2020.08.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 177 |
Rim CH, Shin IS, Lee HY, Yoon WS, Park S. Oncologic Benefit of Adjuvant Chemoradiation after D2 Gastrectomy: A Stepwise Hierarchical Pooled Analysis and Systematic Review. Cancers (Basel) 2020;12:E2125. [PMID: 32751879 DOI: 10.3390/cancers12082125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 178 |
Xie S, Chang Y, Jin H, Yang F, Xu Y, Yan X, Lin A, Shu Q, Zhou T. Non-coding RNAs in gastric cancer. Cancer Lett 2020;493:55-70. [PMID: 32712234 DOI: 10.1016/j.canlet.2020.06.022] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 179 |
Wu Y, Hu G, Wu R, Gong N. High expression of miR-135b predicts malignant transformation and poor prognosis of gastric cancer. Life Sci 2020;257:118133. [PMID: 32710946 DOI: 10.1016/j.lfs.2020.118133] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 180 |
Kong FB, Deng QM, Deng HQ, Dong CC, Li L, He CG, Wang XT, Xu S, Mai W. Siva‑1 regulates multidrug resistance of gastric cancer by targeting MDR1 and MRP1 via the NF‑κB pathway. Mol Med Rep 2020;22:1558-66. [PMID: 32626967 DOI: 10.3892/mmr.2020.11211] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 181 |
Jantrapirom S, Piccolo LL, Pruksakorn D, Potikanond S, Nimlamool W. Ubiquilin Networking in Cancers. Cancers (Basel) 2020;12:E1586. [PMID: 32549375 DOI: 10.3390/cancers12061586] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
